https://assets.capyfin.com/instruments/678fdc13234e27009c5d6034.png avatar
Select Medical
🇺🇸 NYSE:SEM
View Company
OverviewEarningsDividends
•
Jun 30, 2024

Select Medical Q2 2024 Earnings Report

Select Medical's financial performance increased, with revenue and net income rising compared to the same quarter last year.

Key Takeaways

Select Medical Holdings Corporation reported a 5.1% increase in revenue to $1,759.7 million for the second quarter ended June 30, 2024, compared to $1,674.5 million for the same quarter, prior year. Net income increased 3.2% to $94.8 million, and earnings per share were $0.60.

Revenue increased by 5.1% to $1,759.7 million compared to the same quarter last year.

Net income rose by 3.2% to $94.8 million compared to the same quarter last year.

Earnings per share (EPS) was $0.60, compared to $0.61 for the same quarter last year.

Adjusted EBITDA increased by 3.1% to $226.3 million compared to the same quarter last year.

Total Revenue
$1.76B
Previous year: $1.67B
+5.1%
EPS
$0.6
Previous year: $0.61
-1.6%
Gross Profit
$208M
Previous year: $251M
-17.2%
Cash and Equivalents
$111M
Previous year: $101M
+9.9%
Free Cash Flow
$223M
Total Assets
$7.88B
Previous year: $7.7B
+2.3%

Select Medical

Select Medical

Select Medical Revenue by Segment

Forward Guidance

Select Medical reaffirms its 2024 business outlook, expecting revenue in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA in the range of $845 million to $885 million, fully diluted earnings per share in the range of $1.95 to $2.19, and adjusted earnings per share in the range of $1.96 to $2.20.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View Select Medical